Abstract
Schizophrenia is a complex genetic disorder to which genetic variation in the glutamatergic signaling pathways is believed to play a substantial role in the etiology of the disease. Association studies have implicated the N-methyl-d-aspartate receptor subunit gene, GRIN1, as a candidate gene for schizophrenia. In this report, we used a case control study to establish the possible association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia in an Iranian cohort of 200 unrelated patients and 200 controls. The allelic and genotypic frequencies of the polymorphism were determined using polymerase chain reaction restriction fragment length polymorphism. Data analysis using logistic regression and the Mantel–Haenszel chi-square test revealed a strong association between the G1001C polymorphism and schizophrenia (CG genotype: odds ratio (OR) = 2.12, 95% confidence interval (CI) 1.34–3.48, P = 0.001 and CC genotype: OR = 29.10, 95% CI 3.40–565.78, P < 0.001). Furthermore, the C allele is significantly associated with an increasing risk of schizophrenia.
References
Allen, N. C., Bagade, S., McQueen, M. B., et al. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nature Genetics, 40(7), 827–834. doi:10.1038/ng.171.
Begni, S., Moraschi, S., Bignotti, S., et al. (2003). Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biological Psychiatry, 53, 617–619. doi:10.1016/S0006-3223(02)01783-3.
Bertram, L. (2008). Genetic research in schizophrenia: New tools and future perspectives. Schizophrenia Bulletin, 34, 806–812.
Daw, N. W., Stein, P. S. G., Fox, K., et al. (1993). The role of NMDA receptors in information processing. Annual Review of Neuroscience 16, 207-222.
Faraone, S. V., Matise, T., Svrakic, D., et al. (1998). Genome scan of European–American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. American Journal of Medical Genetics, 81, 290–295. doi:10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y.
Fujii, D. E., Wylie, A. M., & Nathan, J. H. (2004). Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness. Schizophrenia Research, 69, 67–73. doi:10.1016/S0920-9964(03)00122-1.
Georgi, A., Jamra, R. A., Klein, K. B., et al. (2007). Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatric Genetics, 17(5), 308–310. doi:10.1097/YPG.0b013e3280c1e5fb.
Goff, D. C., & Coyle, J. T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. The American Journal of Psychiatry, 158, 1367–1377. doi:10.1176/appi.ajp.158.9.1367.
Harrison, P. J., & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Molecular Psychiatry, 10, 40–68. doi:10.1038/sj.mp.4001558.
Hollmann, M., & Heinemann, S. (1994). Cloned glutamate receptors. Annual Review of Neuroscience, 17, 31–108. doi:10.1146/annurev.ne.17.030194.000335.
Hung, C. C., Chen, H. Y., & Chen, C. H. (2002). Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-d-aspartate 1 gene (GRIN1) in schizophrenic patients. Psychiatric Genetics, 12, 225–230. doi:10.1097/00041444-200212000-00005.
Jablensky, A. (2000). Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience, 250, 274–285. doi:10.1007/s004060070002.
Javitt, D. C., & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. The American Journal of Psychiatry, 148, 1301–1308.
Karasawa, J., Hashimoto, K., & Chali, S. H. (2008). d-Serine and a glycine transporter inhibitor improve MK-801-inducedcognitive deficits in a novel object recognition test in rats. Behavioural Brain Research, 186, 78–83. doi:10.1016/j.bbr.2007.07.033.
Lane, H. Y., Chang, Y. C., Liu, Y. C., Chiu, C. C., & Tsai, G. E. (2005). Sarcosine or d-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double blind, placebo-controlled study. Archives of General Psychiatry, 62, 1196–1204. doi:10.1001/archpsyc.62.11.1196.
Martucci, L., Wong, A. H., Trakalo, J., et al. (2003). N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. American Journal of Medical Genetics, 119B, 24–27. doi:10.1002/ajmg.b.20014.
McGuffin, P., Tandon, K., & Corsico, A. (2003). Linkage and association studies of schizophrenia. Current Psychiatry Reports, 5(2), 121–127. doi:10.1007/s11920-003-0028-y.
Meador-Woodruff, J. H., & Healy, D. J. (2000). Glutamate receptor expression in schizophrenic brain. Brain Research Review, 31, 288–294.
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell, 98, 427–436. doi:10.1016/S0092-8674(00)81972-8.
Monyer, H., Sprengel, R., Schoepfer, R., et al. (1992). Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science, 256, 1217–1221. doi:10.1126/science.256.5060.1217.
Qin, S. H., Zhao, X., Pan, Y., et al. (2005). An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. European Journal of Human Genetics, 13, 807–814. doi:10.1038/sj.ejhg.5201418.
Rice, S. R., Niu, N., Berman, D. B., Heston, L. L., & Sobell, J. L. (2001). Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Molecular Psychiatry, 6, 274–284. doi:10.1038/sj.mp.4000838.
Sakurai, K., Toru, M., Yamakawa-Kobayashi, K., & Arinami, T. (2000). Mutation analysis of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neuroscience Letters, 296, 168–170. doi:10.1016/S0304-3940(00)01599-8.
Schork, N. J., Greenwood, T. A., & Braff, D. L. (2006). Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research. Schizophrenia Bulletin, 33(1), 95–104. doi:10.1093/schbul/sbl045.
Tani, A., Kikuta, R., Itoh, K., et al. (2002). Polymorphism analysis of the upstream region of the human N-methyl-d-aspartate receptor upstream region of the human N-methyl-d-aspartate receptor subunit NR1 gene (GRIN1): Implications for schizophrenia. Schizophrenia Research, 58, 83–86. doi:10.1016/S0920-9964(02)00161-5.
VanDongen, A. M., & Van Dongen, H. M. (2004). Effects of mRNA untranslated regions on translational efficiency of NMDA receptor subunits. Neuro-Signals, 13, 194–206. doi:10.1159/000077526.
Williams, N. M., Bowen, T., Spurlock, G., et al. (2002). Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-d-aspartate glutamate receptor. Molecular Psychiatry, 7, 508–514. doi:10.1038/sj.mp.4001030.
Zhao, X., Li, H., Shi, Y., et al. (2006). Signification association between the genetic variations in the 5′ end of the N-methyl-d-aspartate receptor subunit gene GRIN1 and schizophrenia. Biological Psychiatry, 59, 747–753. doi:10.1016/j.biopsych.2005.10.023.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s12031-008-9152-9
Rights and permissions
About this article
Cite this article
Galehdari, H. Association Between the G1001C Polymorphism in the GRIN1 Gene Promoter and Schizophrenia in the Iranian Population. J Mol Neurosci 38, 178–181 (2009). https://doi.org/10.1007/s12031-008-9148-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9148-5